Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cambridge, Massachusetts
- Most recent report
- 10-Q, filed Aug 5, 2026
- Incorporated
- Delaware
- Filings on record
- 882 filings
- On EDGAR
- CIK 1517022
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 51
News 8 of 168
Prospectuses and Registrations 8 of 52
- S-8 Registration statement for an employee plan Aug 5, 2026
- S-8 Registration statement for an employee plan Aug 7, 2025
- 424B5 Prospectus supplement for an offering Mar 20, 2025
- 424B5 Prospectus supplement for an offering Mar 19, 2025
- S-8 Registration statement for an employee plan Jan 30, 2025
- S-3 Shelf registration statement Sep 3, 2024
- S-8 Registration statement for an employee plan Jan 30, 2024
- S-8 Registration statement for an employee plan Jun 6, 2023
Proxies 8 of 39
- DEFA14A Extra proxy material Apr 28, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2026
- PRE 14A Preliminary proxy statement Apr 15, 2026
- DEFA14A Extra proxy material Apr 29, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2025
- DEFA14A Extra proxy material Apr 25, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 25, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2023
Ownership 8 of 481
- 4 Insider reported a trade Aug 10, 2026
- 4 Insider reported a trade Jul 1, 2026
- 144 Notice of a proposed sale of restricted stock Jun 29, 2026
- 4 Insider reported a trade Jun 22, 2026
- 4 Insider reported a trade Jun 22, 2026
- 4 Insider reported a trade Jun 22, 2026
- 4 Insider reported a trade Jun 22, 2026
- 4 Insider reported a trade Jun 22, 2026
Other 8 of 91
- ARS Annual report sent to shareholders Apr 29, 2026
- ARS Annual report sent to shareholders Apr 29, 2025
- EFFECT Notice that a registration became effective Sep 12, 2024
- CORRESP Reply to SEC staff Sep 10, 2024
- UPLOAD Comment letter from SEC staff Sep 9, 2024
- ARS Annual report sent to shareholders Apr 25, 2024
- NT 10-Q Notice that a quarterly report will be late Aug 10, 2023
- ARS Annual report sent to shareholders Apr 28, 2023
Everything here comes from Akebia Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.